Premium
High‐dose salvage chemotherapy. Germ‐cell tumor treatment results in Germany
Author(s) -
Rick Oliver,
Siegert Wolfgang,
Beyer Jörg
Publication year - 1999
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19991210)83:6<839::aid-ijc26>3.0.co;2-a
Subject(s) - germ cell tumors , chemotherapy , salvage therapy , germ cell , refractory (planetary science) , medicine , oncology , clinical trial , biology , biochemistry , astrobiology , gene
During the past 10 years, high‐dose chemotherapy (HDCT) has emerged as a feasible and curative treatment option for patients with multiply relapsed and/or refractory germ‐cell tumors. Increasing experience and the results from clincial trials have helped to optimize the application of HDCT and to define its role in the salvage concepts for germ‐cell tumors. Int. J. Cancer 83:839–840, 1999. © 1999 Wiley‐Liss, Inc.